(PubMed) Hadamitzky M, Distler R, Meyer T, et al
Even separately, hormone therapy and GLP-1s can be much more impactful when you pair them with lifestyle changes
GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways Cancer Network Staff Ariana Pelosci , Tim Cortese Explore 5 essential takeaways for oncology clinicians regarding the use of GLP-1 receptor agonists in breast cancer management
The treatments are quick and virtually painless, making it a convenient addition to your wellness routine
Less commonly, polymorphisms in the MC1R gene (common in individuals with red hair and Fitzpatrick type I skin) reduce receptor responsiveness to exogenous agonists, requiring higher doses or longer loading phases to achieve visible results
In parallel, the viability was scored using resazurin, and the results adjusted for the percentage of viable cells relative to the GSH content of WT cells